P300 Brain Computer Interface Keyboard to Operate Assistive Technology
The P300 Brain Computer Interface Keyboard study, sponsored by the University of Michigan, aims to develop a BCI that enables individuals with paralysis to operate technology using brain signals. This innovative approach addresses a significant market need for assistive technologies, particularly for conditions such as Amyotrophic Lateral Sclerosis, spinal cord injuries, and other neuromuscular diseases. The successful development and commercialization of this technology could position the University of Michigan as a leader in the assistive technology market, which is projected to grow significantly due to increasing demand for adaptive devices. Competitive implications include potential partnerships with technology companies specializing in assistive devices and software, as well as the need to navigate existing patents in the BCI space to ensure freedom-to-operate.
Indication: Healthy
Modality: medical device
Target: Brain Computer Interface (BCI) technology utilizing EEG signals to operate assistive technology.
Sponsor: University of Michigan
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 09, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Brain Computer Interface (BCI) technology utilizing EEG signals to operate assistive technology.
View original source fields
Condition raw: Healthy, Amyotrophic Lateral Sclerosis, Neuromuscular Disease, Spinal Cord Injury, Cerebral Palsy
Condition normalized: Healthy, Amyotrophic Lateral Sclerosis, Neuromuscular Disease, Spinal Cord Injury, Cerebral Palsy
Modality raw: medical device
Modality normalized: medical device
Target raw: Brain Computer Interface (BCI) technology utilizing EEG signals to operate assistive technology.
Target normalized: Brain Computer Interface (BCI) technology utilizing EEG signals to operate assistive technology.